Transgenic mice overexpressing CSF-1 in their mammary epithelium presented an increased breast cancer metastatic potential [45], while overexpression of CSF-1/CSF-1R in human ovarian and breast carcinoma correlates with poor survival outcomes [32]. The gene discussed is CSF1R; the disease is breast carcinoma.